This study evaluated GPT-4's accuracy in MRI sequence selection based on radiology request forms (RRFs), comparing its performance to radiology residents. This retrospective study included 100 RRFs across four subspecialties (cardiac imaging, neuroradiology, musculoskeletal, and oncology). GPT-4 and two radiology residents (R1: 2 years, R2: 5 years MRI experience) selected sequences based on each patient's medical history and clinical questions. Considering imaging society guidelines, five board-certified specialized radiologists assessed protocols based on completeness, quality, and utility in consensus, using 5-point Likert scales. Clinical applicability was rated binarily by the institution's lead radiographer. GPT-4 achieved median scores of 3 (1-5) for completeness, 4 (1-5) for quality, and 4 (1-5) for utility, comparable to R1 (3 (1-5), 4 (1-5), 4 (1-5); each p > 0.05) but inferior to R2 (4 (1-5), 5 (1-5); p < 0.01, respectively, and 5 (1-5); p < 0.001). Subspecialty protocol quality varied: GPT-4 matched R1 (4 (2-4) vs. 4 (2-5), p = 0.20) and R2 (4 (2-5); p = 0.47) in cardiac imaging; showed no differences in neuroradiology (all 5 (1-5), p > 0.05); scored lower than R1 and R2 in musculoskeletal imaging (3 (2-5) vs. 4 (3-5); p < 0.01, and 5 (3-5); p < 0.001); and matched R1 (4 (1-5) vs. 2 (1-4), p = 0.12) as well as R2 (5 (2-5); p = 0.20) in oncology. GPT-4-based protocols were clinically applicable in 95% of cases, comparable to R1 (95%) and R2 (96%). GPT-4 generated MRI protocols with notable completeness, quality, utility, and clinical applicability, excelling in standardized subspecialties like cardiac and neuroradiology imaging while yielding lower accuracy in musculoskeletal examinations. Question Long MRI acquisition times limit patient access, making accurate protocol selection crucial for efficient diagnostics, though it's time-consuming and error-prone, especially for inexperienced residents. Findings GPT-4 generated MRI protocols of remarkable yet inconsistent quality, performing on par with an experienced resident in standardized fields, but moderately in musculoskeletal examinations. Clinical relevance The large language model can assist less experienced radiologists in determining detailed MRI protocols and counteract increasing workloads. The model could function as a semi-automatic tool, generating MRI protocols for radiologists' confirmation, optimizing resource allocation, and improving diagnostics and cost-effectiveness.

Clinical magnetic resonance imaging (MRI) is a high-resolution tool widely used for detailed anatomical imaging. However, prolonged scan times often lead to motion artefacts and patient discomfort. Fast acquisition techniques can reduce scan times but often produce noisy, low-contrast images, compromising segmentation accuracy essential for diagnosis and treatment planning. To address these limitations, we developed an end-to-end framework that incorporates BIDS-based data organiser and anonymizer, a GAN-based MR image enhancement model (GAN-MRI), AssemblyNet for brain region segmentation, and an attention-residual U-Net with Guided loss for abdominal and thigh segmentation. Thirty brain scans (5,400 slices) and 32 abdominal (1,920 slices) and 55 thigh scans (2,200 slices) acquired from multiple MRI scanners (GE, Siemens, Toshiba) underwent evaluation. Image quality improved significantly, with SNR and CNR for brain scans increasing from 28.44 to 42.92 (p < 0.001) and 11.88 to 18.03 (p < 0.001), respectively. Abdominal scans exhibited SNR increases from 35.30 to 50.24 (p < 0.001) and CNR from 10,290.93 to 93,767.22 (p < 0.001). Double-blind evaluations highlighted improved visualisations of anatomical structures and bias field correction. Segmentation performance improved substantially in the thigh (muscle: + 21%, IMAT: + 9%) and abdominal regions (SSAT: + 1%, DSAT: + 2%, VAT: + 12%), while brain segmentation metrics remained largely stable, reflecting the robustness of the baseline model. Proposed framework is designed to handle data from multiple anatomies with variations from different MRI scanners and centres by enhancing MRI scan and improving segmentation accuracy, diagnostic precision and treatment planning while reducing scan times and maintaining patient comfort.

Preoperative T-staging in rectal cancer is essential for treatment planning, yet conventional MRI shows limited accuracy (~ 60-78). Our study investigates whether radiomic analysis of high-resolution T2-weighted MRI can non-invasively improve staging accuracy through a retrospective evaluation in a real-world surgical cohort. This single-center retrospective study included 200 patients (January 2024-April 2025) with pathologically confirmed rectal cancer, all undergoing preoperative high-resolution T2-weighted MRI within one week prior to curative surgery and no neoadjuvant therapy. Manual segmentation was performed using ITK‑SNAP, followed by extraction of 107 radiomic features via PyRadiomics. Feature selection employed mRMR and LASSO logistic regression, culminating in a Rad-score predictive model. Statistical performance was evaluated using ROC curves (AUC), accuracy, sensitivity, specificity, and Delong's test. Among 200 patients, 95 were pathologically staged as T2 and 105 as T3-T4 (55 T3, 50 T4). After preprocessing, 26 radiomic features were retained; key features including ngtdm_contrast and ngtdm_coarseness showed AUC values > 0.70. The LASSO-based model achieved an AUC of 0.82 (95% CI: 0.75-0.89), with overall accuracy of 81%, sensitivity of 78%, and specificity of 84%. Radiomic analysis of standard preoperative T2-weighted MRI provides a reliable, non-invasive method to predict rectal cancer T-stage. This approach has the potential to enhance staging accuracy and inform personalized surgical planning. Prospective multicenter validation is required for broader clinical implementation.

Amyotrophic Lateral Sclerosis is a devastating motor neuron disease characterized by its diagnostic difficulty. Currently, no reliable biomarkers exist in the diagnosis process. In this scenario, our purpose is the application of machine learning algorithms to imaging MRI-derived variables for the development of diagnostic models that facilitate and shorten the process. A dataset of 211 patients (114 ALS, 45 mimic, 22 genetic carriers and 30 control) with MRI-derived features of volumetry, cortical thickness and local iron (via T2* mapping, and visual assessment of susceptibility imaging). A binary classification task approach has been taken to classify patients with and without ALS. A sequential modeling methodology, understood from an iterative improvement perspective, has been followed, analyzing each group's performance separately to adequately improve modelling. Feature filtering techniques, dimensionality reduction techniques (PCA, kernel PCA), oversampling techniques (SMOTE, ADASYN) and classification techniques (logistic regression, LASSO, Ridge, ElasticNet, Support Vector Classifier, K-neighbors, random forest) were included. Three subsets of available data have been used for each proposed architecture: a subset containing automatic retrieval MRI-derived data, a subset containing the variables from the visual analysis of the susceptibility imaging and a subset containing all features. The best results have been attained with all the available data through a voting classifier composed of five different classifiers: accuracy = 0.896, AUC = 0.929, sensitivity = 0.886, specificity = 0.929. These results confirm the potential of ML techniques applied to imaging variables of volumetry, cortical thickness, and local iron for the development of diagnostic model as a clinical tool for decision-making support.

BackgroundAlzheimer's disease (AD) is an irreversible neurodegenerative disorder characterized by progressive cognitive and memory decline. Accurate prediction of high-risk individuals enables early detection and better patient care.ObjectiveThis study aims to enhance MRI-based AD classification through advanced image preprocessing, optimal feature selection, and ensemble deep learning techniques.MethodsThe study employs advanced image preprocessing techniques such as normalization, affine transformation, and denoising to improve MRI quality. Brain structure segmentation is performed using the adaptive DeepLabV3 + approach for precise AD diagnosis. A novel optimal feature selection framework, H-IBMFO, integrates the Improved Beluga Whale Optimizer and Manta Foraging Optimization. An ensemble deep learning model combining MobileNet V2, DarkNet, and ResNet is used for classification. MATLAB is utilized for implementation.ResultsThe proposed system achieves 98.7% accuracy, with 98% precision, 98% sensitivity, 99% specificity, and 98% F-measure, demonstrating superior classification performance with minimal false positives and negatives.ConclusionsThe study establishes an efficient framework for AD classification, significantly improving early detection through optimized feature selection and deep learning. The high accuracy and reliability of the system validate its effectiveness in diagnosing AD stages.

To evaluate the utility of a deep learning (DL)-based image enhancement for improving the image quality and diagnostic performance of 3D contrast-enhanced T1-weighted black blood (BB) MR imaging for brain metastases. This retrospective study included 126 patients with and 121 patients without brain metastasis who underwent 3-T MRI examinations. Commercially available DL-based MR image enhancement software was utilized for image post-processing. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of enhancing lesions were measured. For qualitative assessment and diagnostic performance evaluation, two radiologists graded the overall image quality, noise, and artifacts of each image and the conspicuity of visible lesions. The Wilcoxon signed-rank test and regression analyses with generalized estimating equations (GEEs) were used for statistical analysis. For MR images that were not previously processed using other DL-based methods, SNR and CNR were higher in the DL-enhanced images than in the standard images (438.3 vs. 661.1, p < 0.01; 173.9 vs. 223.5, p < 0.01). Overall image quality and noise were improved in the DL images (p < 0.01, average score-5 proportion 38% vs. 65%; p < 0.01, 43% vs. 74%), whereas artifacts did not significantly differ (p ≥ 0.07). Sensitivity was increased after post-processing from 79 to 86% (p = 0.02), especially for lesions smaller than 5 mm (69 to 78%, p = 0.03), and changes in specificity (p = 0.24) and average false-positive (FP) count (p = 0.18) were not significant. DL image enhancement improves the image quality and diagnostic performance of 3D contrast-enhanced T1-weighted BB MR imaging for the detection of small brain metastases. Question Can deep learning (DL)-based image enhancement improve the image quality and diagnostic performance of 3D contrast-enhanced T1-weighted black blood (BB) MR imaging for brain metastases? Findings DL-based image enhancement improved image quality of thin slice BB MR images and sensitivity for brain metastasis, particularly for lesions smaller than 5 mm. Clinical relevance DL-based image enhancement on BB images may assist in the accurate diagnosis of brain metastasis by achieving better sensitivity while maintaining comparable specificity.

Accurate detection of brain tumors remains a significant challenge due to the diversity of tumor types along with human interventions during diagnostic process. This study proposes a novel ensemble deep learning system for accurate brain tumor classification using MRI data. The proposed system integrates fine-tuned Convolutional Neural Network (CNN), ResNet-50 and EfficientNet-B5 to create a dynamic ensemble framework that addresses existing challenges. An adaptive dynamic weight distribution strategy is employed during training to optimize the contribution of each networks in the framework. To address class imbalance and improve model generalization, a customized weighted cross-entropy loss function is incorporated. The model obtains improved interpretability through explainabile artificial intelligence (XAI) techniques, including Grad-CAM, SHAP, SmoothGrad, and LIME, providing deeper insights into prediction rationale. The proposed system achieves a classification accuracy of 99.4% on the test set, 99.48% on the validation set, and 99.31% in cross-dataset validation. Furthermore, entropy-based uncertainty analysis quantifies prediction confidence, yielding an average entropy of 0.3093 and effectively identifying uncertain predictions to mitigate diagnostic errors. Overall, the proposed framework demonstrates high accuracy, robustness, and interpretability, highlighting its potential for integration into automated brain tumor diagnosis systems.

Breast cancer (BC) is a kind of cancer that is created from the cells in breast tissue. This is a primary cancer that occurs in women. Earlier identification of BC is significant in the treatment process. To lessen unwanted biopsies, Magnetic Resonance Imaging (MRI) is utilized for diagnosing BC nowadays. MRI is the most recommended examination to detect and monitor BC and explain lesion areas as it has a better ability for soft tissue imaging. Even though, it is a time-consuming procedure and requires skilled radiologists. Here, Breast Cancer Deep Convolutional Neural Network (BCDCNN) is presented for Breast Cancer Detection (BCD) using MRI images. At first, the input image is taken from the database and subjected to a pre-processing segment. Adaptive Kalman filter (AKF) is utilized to execute the pre-processing phase. Thereafter, cancer area segmentation is conducted on filtered images by Pyramid Scene Parsing Network (PSPNet). To improve segmentation accuracy and adapt to complex tumor boundaries, PSPNet is optimized using the Jellyfish Search Optimizer (JSO). It is a recent nature-inspired metaheuristic that converges to an optimal solution in fewer iterations compared to conventional methods. Then, image augmentation is performed that includes augmentation techniques namely rotation, random erasing and slipping. Afterwards, feature extraction is done and finally, BCD is conducted employing BCDCNN, wherein the loss function is newly designed based on an adaptive error similarity. It improves the overall performance by dynamically emphasizing samples with ambiguous predictions, enabling the model to focus more on diagnostically challenging cases and enhancing its discriminative capability. Furthermore, BCDCNN acquired 90.2% of accuracy, 90.6% of sensitivity and 90.9% of specificity. The proposed method not only demonstrates strong classification performance but also holds promising potential for real-world clinical application in early and accurate breast cancer diagnosis.

Large Language Models (LLMs) offer a promising solution for extracting structured clinical information from free-text radiology reports. The Simplified Magnetic Resonance Index of Activity (sMARIA) is a validated scoring system used to quantify Crohn's disease (CD) activity based on Magnetic Resonance Enterography (MRE) findings. This study aims to evaluate the performance of two advanced LLMs in extracting key imaging features and computing sMARIA scores from free-text MRE reports. This retrospective study included 117 anonymized free-text MRE reports from patients with confirmed CD. ChatGPT (GPT-4o) and DeepSeek (DeepSeek-R1) were prompted using a structured input designed to extract four key radiologic features relevant to sMARIA: bowel wall thickness, mural edema, perienteric fat stranding, and ulceration. LLM outputs were evaluated against radiologist annotations at both the segment and feature levels. Segment-level agreement was assessed using accuracy, mean absolute error (MAE) and Pearson correlation. Feature-level performance was evaluated using sensitivity, specificity, precision, and F1-score. Errors including confabulations were recorded descriptively. ChatGPT achieved a segment-level accuracy of 98.6%, MAE of 0.17, and Pearson correlation of 0.99. DeepSeek achieved 97.3% accuracy, MAE of 0.51, and correlation of 0.96. At the feature level, ChatGPT yielded an F1-score of 98.8% (precision 97.8%, sensitivity 99.9%), while DeepSeek achieved 97.9% (precision 96.0%, sensitivity 99.8%). LLMs demonstrate near-human accuracy in extracting structured information and computing sMARIA scores from free-text MRE reports. This enables automated assessment of CD activity without altering current reporting workflows, supporting longitudinal monitoring and large-scale research. Integration into clinical decision support systems may be feasible in the future, provided appropriate human oversight and validation are ensured.

CNS cancers are complex, difficult-to-treat malignancies that remain insufficiently understood and mostly incurable, despite decades of research efforts. Artificial intelligence (AI) is poised to reshape neuro-oncological practice and research, driving advances in medical image analysis, neuro-molecular-genetic characterisation, biomarker discovery, therapeutic target identification, tailored management strategies, and neurorehabilitation. This Review examines key opportunities and challenges associated with AI applications along the neuro-oncological care trajectory. We highlight emerging trends in foundation models, biophysical modelling, synthetic data, and drug development and discuss regulatory, operational, and ethical hurdles across data, translation, and implementation gaps. Near-term clinical translation depends on scaling validated AI solutions for well defined clinical tasks. In contrast, more experimental AI solutions offer broader potential but require technical refinement and resolution of data and regulatory challenges. Addressing both general and neuro-oncology-specific issues is essential to unlock the full potential of AI and ensure its responsible, effective, and needs-based integration into neuro-oncological practice.